Charterhouse, a private equity firm, completed the investment in Skin Tech Pharma, a global medical aesthetics group. Financial terms were not disclosed. “We are immensely proud of Skin Tech’s success since the foundation of the business over 25 years ago. Our product portfolio is highly regarded by practitioners around the world, and we are excited to continue driving innovation to meet the needs of our customers. We look forward to working with Charterhouse as we enter this next phase of the company’s development, capitalising on a wide range of opportunities to drive Skin Tech’s growth for the future," Philippe Deprez, Skin Tech Founder and CEO.